Effects of Mesenchymal Stem Cells Therapy on Cardiovascular Risk Factors in Experimental Diabetic Kidney Disease
Background: Diabetic kidney disease (DKD) is a progressive kidney disease and a leading cause of end-stage renal disease (ESRD). Diabetic kidney disease has been strongly associated with increased risk of cardiovascular morbidity and mortality. Despite their susceptibility to cardiovascular diseases...
Main Authors: | Einas Nagib Hussein, Gehane M. Hamed, Ansam A. Seif, Mona A. Ahmed, Fatma Abd Elkarim Abu Zahra |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-10-01
|
Series: | Canadian Journal of Kidney Health and Disease |
Online Access: | https://doi.org/10.1177/2054358120957429 |
Similar Items
-
Use of mesenchymal stem cells for chronic kidney disease
by: Byung Ha Chung
Published: (2019-06-01) -
Mesenchymal Stem Cells—Potential Applications in Kidney Diseases
by: Benjamin Bochon, et al.
Published: (2019-05-01) -
Mesenchymal Stem Cell Insights: Prospects in Cardiovascular Therapy
by: Shiu-Huey Chou, et al.
Published: (2014-05-01) -
Role of mesenchymal stem cells and their culture medium in alleviating kidney injury in rats diabetic nephropathy
by: Amal Al-Shahat Ibrahim, et al.
Published: (2020-05-01) -
Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular Disease
by: Ranganath, Sudhir H, et al.
Published: (2014)